This document, labeled HOUSE_OVERSIGHT_028422, is a JSON data file containing metadata for several New York Times articles delivered via Apple News. The content, primarily dated September 24, 2018, concerns the 2018 New Jersey Senate race between Robert Menendez and former Celgene executive Bob Hugin. It also references a related article about Celgene settling a $280 million fraud lawsuit in 2017.
| Name | Role | Context |
|---|---|---|
| Robert J. Hugin | Former Pharmaceutical Executive, U.S. Senate Candidate |
Mentioned in keywords and article summaries as a former executive (of Celgene) running for U.S. Senate in New Jersey ...
|
| Robert Menendez | U.S. Senator |
Mentioned in keywords and article summaries as being in a Senate election battle against Bob Hugin in New Jersey.
|
| Name | Type | Context |
|---|---|---|
| Celgene Corporation |
Pharmaceutical company mentioned in keywords. An article summary states they paid $280 million to settle a fraud suit...
|
|
| New York Times |
The publisher of the news articles described in the JSON data.
|
|
| Food and Drug Administration |
Mentioned as a keyword in the article metadata.
|
|
| AppleNews |
Mentioned as the partner for content delivery in the article URLs.
|
|
| HOUSE_OVERSIGHT |
Appears as a footer/label on the document, likely indicating it is part of a file from the House Oversight Committee.
|
| Location | Context |
|---|---|
|
The location of the U.S. Senate election battle between Hugin and Menendez.
|
|
|
nyregion
|
The section of the New York Times website where the articles are hosted.
|
"Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs"Source
"In Deeply Blue New Jersey, an Unexpected Battle for Senate"Source
"A Former Pharmaceutical Executive Is Running for U.S. Senate in New Jersey"Source
"Get the full New York Times experience"Source
Complete text extracted from the document (4,858 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document